MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.intimp.2024.112694

Медицинская библиотека · International immunopharmacology · 2024

Metabolic syndrome induces benefits in mice experiencing severe sepsis, comparable to the effects of low-dose aspirin pretreatment in septic mice lacking metabolic syndrome.

Nakama Raquel Pires, Dos Santos Lucas Felipe, Berto-Pereira Leonardo, de Rossi Lucas Sobral, Malvezi Aparecida Donizette, Lovo-Martins Maria Isabel, Canizares Cardoso Ana Paula, de Freitas Andressa Mendes Dionísio, Martins-Pinge Marli Cardoso, Pinge-Filho Phileno

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Sepsis is a complex condition characterized by systemic host inflammation caused by an infection. Experimental and observational studies indicate that obesity, one of the components of metabolic syndrome (MetS), or aspirin (ASA) treatment could be associated with sepsis survival. However, the effects of ASA on septic mice with MetS-induced conditions have not been explored.

METHODS

Swiss mice were administered monosodium glutamate (MSG) (4 mg/kg) during their first 5 days of life for MetS induction, while the control mice received an equimolar saline solution. MetS was validated in male mice on their 60th day of life. ASA treatment was administered for 15 days prior to sepsis (40 mg/kg). On the 75th day, sepsis was induced in MetS and control mice through cecal ligation and puncture (CLP). The effects of ASA on septic mice with MSG-induced MetS were assessed by determining survival rates, quantification of nitric oxide (NO), and cytokine levels in the plasma, while correlating these data with hematological, blood glucose and cardiovascular parameters.

RESULTS

MetS was validated by Lee-Index (3 body weight/naso-anal length×1000), hypertension, and hyperglycemia in animals receiving MSG as neonates. In control animals, severe sepsis promoted hypoglycemia, which was associated with mortality, as well as increased plasma NO levels, hypotension, hematological alterations, and elevation of proinflammatory cytokines. In contrast, MetS and pre-treatment with ASA were able to prevent sepsis-related alterations.

CONCLUSIONS

MetS and ASA pre-treatment provided protection against severe sepsis. However, ASA was ineffective in mice with MetS undergoing severe sepsis.

Для цитирования: Nakama Raquel Pires, Dos Santos Lucas Felipe, Berto-Pereira Leonardo, de Rossi Lucas Sobral, Malvezi Aparecida Donizette, Lovo-Martins Maria Isabel, Canizares Cardoso Ana Paula, de Freitas Andressa Mendes Dionísio, Martins-Pinge Marli Cardoso, Pinge-Filho Phileno. Metabolic syndrome induces benefits in mice experiencing severe sepsis, comparable to the effects of low-dose aspirin pretreatment in septic mice lacking metabolic syndrome.. International immunopharmacology. 2024. DOI: 10.1016/j.intimp.2024.112694.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.